Bookmark this page — track this journal's Journal Metrics Score, quartile and field rankings with every OpenAlex data release.
2026 Journal Metrics Score
1.0
Updated August 2026 · 2-year citation average from OpenAlex data
The Journal Metrics Score is the two-year mean citedness of a journal, computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works. Quartiles rank journals within each OpenAlex subfield by score. Data source: OpenAlex (CC0).
| Category | Quartile |
|---|---|
| Radiology, Nuclear Medicine and Imaging | Q4 |
| Cancer Research | Q4 |
Use your manuscript title to find AI-ranked journals with related recent work, fit reasons, risks, and submission strategy.
Cancer Biotherapy and Radiopharmaceuticals's 2026 Journal Metrics Score is 1.0, updated August 2026 from OpenAlex citation data. The journal is ranked Q4 in this Journal Metrics record.
Use this record to check the journal title, ISSN, subfield quartile, CAS block, publisher details, and similar journals before comparing publication venues.
If you searched for Cancer Biotherapy and Radiopharmaceuticals metrics, compare this exact title record with the journal homepage and nearby journals in the same field. That helps avoid mixing this journal with a similarly named title, abbreviation, society series, or outdated metric snippet.
This page is designed for exact-title searches such as Cancer Biotherapy and Radiopharmaceuticals journal metrics. First confirm that the ISSN and title match this record before using the metric in a journal shortlist or submission decision.
For high-stakes submission decisions, verify the title against the publisher record at the journal homepage, the journal's open catalog record (View on OpenAlex), and the context in our methodology. Treat the subfield quartile, article volume, and similar journals as supporting context rather than a single-number publication decision.
Ranked #683 in Oncology by Journal Metrics Score and #9 among Q4 Oncology journals. This context helps compare Cancer Biotherapy and Radiopharmaceuticals against journals publishing in the same field.
Published 300 papers across the last 5 recorded years with a current Journal Metrics Score of 1.0.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.